Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

caprotec bioanalytics Announces Issuance In Europe of All Core Patents of Its CCMS Technology

February 28, 2011 By Bio-Medicine.Org

BERLIN, and BURLINGTON, Mass., Feb. 28, 2011 /PRNewswire/ —
caprotec bioanalytics GmbH announced today that the European
Patent Office has granted the last of three core patents protecting
its proprietary and revolutionary Capture Compound Mass
Spectrometry (CCMS) technology.  

CCMS offers a novel and direct way to investigate small molecule
– protein interactions resulting in a significant functional
reduction of proteome complexity. The core of the CCMS technology
consists of tri-functional small molecules called Capture
Compounds™.  These Capture Compounds enable the direct
isolation and identification of selected proteins, including
membrane proteins, out of any complex biological sample.

An important application of the CCMS technology is to profile
small molecule drug – protein interactions in the human proteome to
discover or confirm relevant protein drug targets, the mode of drug
action, and off-target proteins potentially causing adverse side
effects in humans.

The newly granted European Patent No. EP 1583972 titled “Methods
for Identifying Drug Non-targets” covers the use of CCMS technology
for lead optimization and risk assessment of candidate drugs to
make a go or no-go decision to enter the clinical trial phase.
 The European Patent No.  EP  1485707 titled
“Compounds and Methods for Analyzing the Proteome” covers Capture
Compounds and methods to discover protein biomarkers for diagnostic
applications. European Patent No. EP 1502102 titled “Compounds and
Methods for Analyzing the Proteome” covers an array-based
application of CCMS technology.  Equivalent patents have been
issued in many major countries.

“We are pleased about the grant of the last of our three core
CCMS patents in Europe, which protect our proprietary technology
and endorse the uniqueness of this powerful proteome analysis
technology,” states Prof. Dr. Hubert Koester, Founder and Chief
Executive Officer of caprot

‘/>”/>

SOURCE

Related Articles Read More >

Blackrock's Utah array is a miniature array of electrodes for sensing brain signals
Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
Engineer inspecting artificial hip joint parts in quality control department in orthopaedic factory
Deburring and finishing for beautiful, functional medical devices
A Medtronic HVAD pump opened up to show the inner workings
FDA designates new Medtronic HVAD pump implant recall as Class I
Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7

DeviceTalks Weekly.

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech